Changes in food intake, metabolic parameters and insulin resistance are induced by an isoenergetic, medium-chain fatty acid diet and are associated with modifications in insulin signalling in isolated rat pancreatic islets

British Journal of Nutrition

Volumn 109, Issue 12, 2013, Pages 2154-2165

  Marcal A C ^a   Camporez, J P G ^a   Lima Salgado, T M ^a   Cintra, D E ^b   Akamine, E H ^a   Ribeiro, L M ^a   Almeida, F N ^a   Zanuto, R P ^a   Curi, R ^a   Boldrini, S C ^a,e   Liberti, E A ^a   Fiamoncini, J ^a   Hirabara, S M ^c   Deschamps, F C ^d   Carpinelli, A R ^a   Carvalho, C R O ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSIDADE CRUZEIRO DO SUL   (Brazil)

^d EMPRESA DE PESQUISA AGROPECUÁRIA E EXTENSÃO RURAL DE SANTA CATARINA   (Brazil)

^e FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

Insulin resistance; Insulin signalling; Medium chain fatty acids; Pancreatic islets

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MEDIUM CHAIN FATTY ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY GROWTH; CELL DEATH; CELL ISOLATION; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FAT INTAKE; FOOD INTAKE; GLUCOSE STIMULATED INSULIN SECRETION; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; MALE; METABOLIC REGULATION; NONHUMAN; OBESITY; PANCREAS ISLET CELL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; DIETARY FATS; DISEASE MODELS, ANIMAL; FATTY ACIDS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; ISLETS OF LANGERHANS; MALE; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RECEPTOR, INSULIN; TRIGLYCERIDES;

ANIMALIA; RATTUS;

EID: 84878395817     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512004576     Document Type: Article

References (72)

1. Albala C, Vio F, Kain J, et al. (2001) Nutrition transition in Latin America: the case of Chile. Nutr Rev 59, 170-176. (Pubitemid 32613761)
2. Amuna P & Zotor FB (2008) Epidemiological and nutrition transition in developing countries: impact on human health and development. Proc Nutr Soc 67, 82-90. (Pubitemid 351185360)
3. Nagao K & Yanagita T (2010) Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome. Pharmacol Res 61, 208-212.
4. Steyn NP, Mann J, Bennett PH, et al. (2004) Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr 7, 147-165. (Pubitemid 38294515)
5. Lichtenstein AH, Kennedy E, Barrier P, et al. (1998) Dietary fat consumption and health. Nutr Rev 56, S3-S19, discussion S19-S28.
6. Aoyama T, Nosaka N & Kasai M (2007) Research on the nutritional characteristics of medium-chain fatty acids. J Med Invest 54, 385-388. (Pubitemid 350143756)
7. Ahrén B (2000) Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia 43, 393-410. (Pubitemid 30237947)
8. Malaisse WJ, Dunlop ME, Mathias PC, et al. (1985) Stimulation of protein kinase C and insulin release by 1-oleoyl-2-acetyl-glycerol. Eur J Biochem 149, 23-27. (Pubitemid 15013483)
9. Malaisse WJ, Carpinelli AR, Lebrun P, et al. (1981) The stimulussecretion coupling of amino acid-induced insulin release. IV. Ionic response to L-leucine and L-glutamine. Pflugers Arch 391, 112-118. (Pubitemid 11012979)
10. MacDonald PE, Joseph JW & Rorsman P (2005) Glucosesensing mechanisms in pancreatic beta-cells. Philos Trans R Soc Lond B Biol Sci 360, 2211-2225.
11. Araujo EP, Amaral ME, Filiputti E, et al. (2004) Restoration of insulin secretion in pancreatic islets of protein-deficient rats by reduced expression of insulin receptor substrate (IRS)-1 and IRS-2. J Endocrinol 181, 25-38. (Pubitemid 38584661)
12. Pende M, Kozma SC, Jaquet M, et al. (2000) Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature 408, 994-997. (Pubitemid 32103292)
13. Tuttle RL, Gill NS, Pugh W, et al. (2001) Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 7, 1133-1137. (Pubitemid 33010022)
14. Elghazi L, Rachdi L, Weiss AJ, et al. (2007) Regulation of betacell mass and function by the Akt/protein kinase B signalling pathway. Diabetes Obes Metab 9, Suppl. 2, 147-157. (Pubitemid 47543137)
15. Haber EP, Procópio J, Carvalho CR, et al. (2006) New insights into fatty acid modulation of pancreatic beta-cell function. Int Rev Cytol 248, 1-41. (Pubitemid 43238169)
16. Nogueira TCA, Graciano MF, Anhê GF, et al. (2009) Short-term modulation of extracellular signal-regulated kinase 1/2 and stress-activated protein kinase/c-Jun NH2-terminal kinase in pancreatic islets by glucose and palmitate: possible involvement of ceramide. Pancreas 38, 585-592.
17. D'Aleo V, Del Guerra S, Martano M, et al. (2009) The nonpeptidyl low molecular weight radical scavenger IAC protects human pancreatic islets from lipotoxicity. Mol Cell Endocrinol 309, 63-66.
18. Diakogiannaki E, Dhayal S, Childs CE, et al. (2007) Mechanisms involved in the cytotoxic and cytoprotective actions of saturated versus monounsaturated long-chain fatty acids in pancreatic beta-cells. J Endocrinol 194, 283-291. (Pubitemid 47249667)
19. Akerfeldt MC & Laybutt DR (2011) Inhibition of Id1 augments insulin secretion and protects against high-fat diet-induced glucose intolerance. Diabetes 60, 2506-2514.
20. Nogueira TCA, Anhê GF, Carvalho CR, et al. (2008) Involvement of phosphatidylinositol-3 kinase/AKT/PKCzeta/lambda pathway in the effect of palmitate on glucoseinduced insulin secretion. Pancreas 37, 309-315.
21. Haber EP, Ximenes HM, Procópio J, et al. (2003) Pleiotropic effects of fatty acids on pancreatic beta-cells. J Cell Physiol 194, 1-12. (Pubitemid 35424222)
22. Calder PC, Jensen GL, Koletzko BV, et al. (2010) Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med 36, 735-749.
23. Bach AC & BabayanV K (1982) Medium-chain triglycerides: an update. Am J Clin Nutr 36, 950-962. (Pubitemid 13214366)
24. Nebeling LC & Lerner E (1995) Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer. J Am Diet Assoc 95, 693-697.
25. Diniz YS, Faine LA, Galhardi CM, et al. (2005) Monosodium glutamate in standard and high-fiber diets: metabolic syndrome and oxidative stress in rats. Nutrition 21, 749-755. (Pubitemid 40733571)
26. Diniz YS, Faine LA, Almeida JA, et al. (2002) Toxicity of dietary restriction of fat enriched diets on cardiac tissue. Food Chem Toxicol 40, 1893-1899. (Pubitemid 35284160)
27. Bordin S, Boschero AC, Carneiro EM, et al. (1995) Ionic mechanisms involved in the regulation of insulin secretion by muscarinic agonists. J Membr Biol 148, 177-184.
28. Marçal AC, Grassiolli S, da Rocha DN, et al. (2006) The dual effect of isoproterenol on insulin release is suppressed in pancreatic islets from hypothalamic obese rats. Endocrine 29, 445-449. (Pubitemid 44358834)
29. Folch J, Lees M & Sloane-Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
30. Hartman L & Lago RC (1973) Rapid preparation of fatty acid methyl esters from lipids. Lab Pract 22, 475-476 passim.
31. Cardoso AR, Carvalho CR, Velloso LA, et al. (2005) Effect of thiopental, pentobarbital and diethyl ether on early steps of insulin action in liver and muscle of the intact rat. Life Sci 76, 2287-2297. (Pubitemid 40313417)
32. Lee MY, Koh JH, Nam SM, et al. (2008) Short insulin tolerance test can determine the effects of thiazolidinediones treatment in type 2 diabetes. Yonsei Med J 49, 901-908.
33. Crettaz M, Prentki M, Zaninetti D, et al. (1980) Insulin resistance in soleus muscle from obese Zucker rats. Involvement of several defective sites. Biochem J 186, 525-534. (Pubitemid 10097491)
34. Lund S, Holman GD, Schmitz O, et al. (1995) Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 92, 5817-5821.
35. Hirabara SM, Silveira LR, Abdulkader F, et al. (2007) Timedependent effects of fatty acids on skeletal muscle metabolism. J Cell Physiol 210, 7-15. (Pubitemid 44904696)
36. Hirabara SM, Silveira LR, Alberici LC, et al. (2006) Acute effect of fatty acids on metabolism and mitochondrial coupling in skeletal muscle. Biochim Biophys Acta 1757, 57-66. (Pubitemid 43113322)
37. Leighton B, Budohoski L, Lozeman FJ, et al. (1985) The effect of prostaglandins E1, E2 and F2 alpha and indomethacin on the sensitivity of glycolysis and glycogen synthesis to insulin in stripped soleus muscles of the rat. Biochem J 227, 337-340. (Pubitemid 15086977)
38. Lacy PE & Kostianovsky M (1967) Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16, 35-39.
39. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
40. Nicoletti I, Migliorati G, Pagliacci MC, et al. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139, 271-279.
41. Ferreira DS, Amaral FG, Mesquita CC, et al. (2012) Maternal melatonin programs the daily pattern of energy metabolism in adult offspring. PLoS One 7, e38795.
42. Rothenberg PL, Lane WS, Karasik A, et al. (1991) Purification and partial sequence analysis of pp 185, the major cellular substrate of the insulin receptor tyrosine kinase. J Biol Chem 266, 8302-8311. (Pubitemid 21906511)
43. Li PM & Goldstein BJ (1996) Cell density-dependent changes in the insulin action pathway: evidence for involvement of protein-tyrosine phosphatases. J Cell Biochem 61, 31-38. (Pubitemid 26134173)
44. Kasai M, Nosaka N, Maki H, et al. (2002) Comparison of dietinduced thermogenesis of foods containing medium-versus long-chain triacylglycerols. J Nutr Sci Vitaminol 48, 536-540. (Pubitemid 36417629)
45. Opara EC, Garfinkel M, Hubbard VS, et al. (1994) Effect of fatty acids on insulin release: role of chain length and degree of unsaturation. Am J Physiol 266, E635-E639.
46. Kashiwaya Y, Pawlosky R, Markis W, et al. (2010) A ketone ester diet increases brain malonyl-CoA and uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar rat. J Biol Chem 285, 25950-25956.
47. Iwata K, Kinoshita M, Yamada S, et al. (2011) Involvement of brain ketone bodies and the noradrenergic pathway in diabetic hyperphagia in rats. J Physiol Sci 61, 103-113.
48. Haas RH, Rice MA, Trauner DA, et al. (1986) Therapeutic effects of a ketogenic diet in Rett syndrome. Am J Med Genet Suppl 1, 225-246. (Pubitemid 16081513)
49. Trauner DA (1985) Medium-chain triglyceride (MCT) diet in intractable seizure disorders. Neurology 35, 237-238. (Pubitemid 15171524)
50. De Vogel-van den Bosch J, van den Berg SA, Bijland S, et al. (2011) High-fat diets rich in medium-versus long-chain fatty acids induce distinct patterns of tissue specific insulin resistance. J Nutr Biochem 22, 366-371.
51. Ahrén B, Sauerberg P & Thomsen C (1999) Increased insulin secretion and normalization of glucose tolerance by cholinergic agonism in high fat-fed mice. Am J Physiol 277, E93-102.
52. Chen NG & Romsos DR (1995) Enhanced sensitivity of pancreatic islets from preobese 2-week-old ob/ob mice to neurohormonal stimulation of insulin secretion. Endocrinology 136, 505-511.
53. Ahrén B & Lundquist I (1982) Modulation of basal insulin secretion in the obese, hyperglycemic mouse. Metab Clin Exp 31, 172-179. (Pubitemid 12222534)
54. Balbo SL, Grassiolli S, Ribeiro RA, et al. (2007) Fat storage is partially dependent on vagal activity and insulin secretion of hypothalamic obese rat. Endocrine 31, 142-148. (Pubitemid 350195148)
55. Del Rio G, Procopio M, Bondi M, et al. (1997) Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects. Int J Obes Relat Metab Disord 21, 1111-1114. (Pubitemid 27511484)
56. Boschero AC, Szpak-Glasman M, Carneiro EM, et al. (1995) Oxotremorine-m potentiation of glucose-induced insulin release from rat islets involves M3 muscarinic receptors. Am J Physiol 268, E336-E342.
57. Straub SG & Sharp GWG (2002) Glucose-stimulated signaling pathways in biphasic insulin secretion. Diabetes Metab Res Rev 18, 451-463. (Pubitemid 36041600)
58. Yang Y & Gillis KD (2004) A highly Ca2\+-sensitive pool of granules is regulated by glucose and protein kinases in insulin-secreting INS-1 cells. J Gen Physiol 124, 641-651. (Pubitemid 39628132)
59. Stein DT, Stevenson BE, Chester MW, et al. (1997) The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100, 398-403. (Pubitemid 27349087)
60. Bach A, Phan T & Metais P (1976) Effect of the fatty acid composition of ingested fats on rat liver intermediary metabolism. Horm Metab Res 8, 375-379.
61. Hill JO, Peters JC, Swift LL, et al. (1990) Changes in blood lipids during six days of overfeeding with medium or long chain triglycerides. J Lipid Res 31, 407-416. (Pubitemid 20107981)
62. Cnop M (2008) Fatty acids and glucolipotoxicity in the pathogenesis of type 2 diabetes. Biochem Soc Trans 36, 348-352. (Pubitemid 351839329)
63. Haber EP, Hirabara SM, Gomes AD, et al. (2003) Palmitate modulates the early steps of insulin signalling pathway in pancreatic islets. FEBS Lett 544, 185-188. (Pubitemid 36628059)
64. PorzioO, Federici M, HribalML, et al. (1999) The Gly972 ! Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. J Clin Invest 104, 357-364.
65. Kulkarni RN, Winnay JN, Daniels M, et al. (1999) Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J Clin Invest 104, R69-R75. (Pubitemid 30053195)
66. Medina MC, Souza LC, Caperuto LC, et al. (2006) Dehydroepiandrosterone increases beta-cell mass and improves the glucose-induced insulin secretion by pancreatic islets from aged rats. FEBS Lett 580, 285-290. (Pubitemid 43005351)
67. Briaud I, Lingohr MK, Dickson LM, et al. (2003) Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic beta-cells. Diabetes 52, 974-983. (Pubitemid 36388732)
68. Amaral MEC, Cunha DA, Anhê GF, et al. (2004) Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy. J Endocrinol 183, 469-476. (Pubitemid 40057577)
69. Boulton TG, Nye SH, Robbins DJ, et al. (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65, 663-675.
70. Meloche S & Pouysségur J (2007) The ERK1/2 mitogenactivated protein kinase pathway as a master regulator of the G1-to S-phase transition. Oncogene 26, 3227-3239. (Pubitemid 46763017)
71. Bonner-Weir S (2000) Life and death of the pancreatic beta cells. Trends Endocrinol Metab 11, 375-378.
72. Rhodes CJ (2005) Type 2 diabetes-a matter of beta-cell life and death? Science 307, 380-384. (Pubitemid 40139973)